Literature DB >> 23752112

Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study.

Elie Azoulay1, Djamel Mokart, Frédéric Pène, Jérôme Lambert, Achille Kouatchet, Julien Mayaux, François Vincent, Martine Nyunga, Fabrice Bruneel, Louise-Marie Laisne, Antoine Rabbat, Christine Lebert, Pierre Perez, Marine Chaize, Anne Renault, Anne-Pascale Meert, Dominique Benoit, Rebecca Hamidfar, Mercé Jourdain, Michael Darmon, Benoit Schlemmer, Sylvie Chevret, Virginie Lemiale.   

Abstract

PURPOSE Patients with hematologic malignancies are increasingly admitted to the intensive care unit (ICU) when life-threatening events occur. We sought to report outcomes and prognostic factors in these patients. PATIENTS AND METHODS Ours was a prospective, multicenter cohort study of critically ill patients with hematologic malignancies. Health-related quality of life (HRQOL) and disease status were collected after 3 to 6 months. Results Of the 1,011 patients, 38.2% had newly diagnosed malignancies, 23.1% were in remission, and 24.9% had received hematopoietic stem-cell transplantations (HSCT, including 145 allogeneic). ICU admission was mostly required for acute respiratory failure (62.5%) and/or shock (42.3%). On day1, 733 patients (72.5%) received life-supporting interventions. Hospital, day-90, and 1-year survival rates were 60.7%, 52.5%, and 43.3%, respectively. By multivariate analysis, cancer remission and time to ICU admission less than 24 hours were associated with better hospital survival. Poor performance status, Charlson comorbidity index, allogeneic HSCT, organ dysfunction score, cardiac arrest, acute respiratory failure, malignant organ infiltration, and invasive aspergillosis were associated with higher hospital mortality. Mechanical ventilation (47.9% of patients), vasoactive drugs (51.2%), and dialysis (25.9%) were associated with mortality rates of 60.5%, 57.5%, and 59.2%, respectively. On day 90, 80% of survivors had no HRQOL alterations (physical and mental health similar to that of the overall cancer population). After 6 months, 80% of survivors had no change in treatment intensity compared with similar patients not admitted to the ICU, and 80% were in remission. CONCLUSION Critically ill patients with hematologic malignancies have good survival, disease control, and post-ICU HRQOL. Earlier ICU admission is associated with better survival.

Entities:  

Mesh:

Year:  2013        PMID: 23752112     DOI: 10.1200/JCO.2012.47.2365

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  163 in total

1.  [Intensive care management of hematological and oncological patients].

Authors:  M von Bergwelt-Baildon; A Shimabukuro-Vornhagen; M Hallek; M Kochanek
Journal:  Internist (Berl)       Date:  2013-09       Impact factor: 0.743

Review 2.  What are the ethical aspects surrounding intensive care unit admission in patients with cancer?

Authors:  Jean-Philippe Rigaud; Audrey Large; Nicolas Meunier-Beillard; Stéphanie Gélinotte; Pierre-Louis Declercq; Fiona Ecarnot; Auguste Dargent; Jean-Pierre Quenot
Journal:  Ann Transl Med       Date:  2017-12

3.  Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: results from a prospective, multicenter registry.

Authors:  J P J van Gestel; M B Bierings; S Dauger; J-H Dalle; P Pavlíček; P Sedláček; L M Monteiro; A Lankester; C W Bollen
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

4.  New puzzles for the use of non-invasive ventilation for immunosuppressed patients.

Authors:  Carmen Sílvia Valente Barbas; Ary Serpa Neto
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

Review 5.  The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Authors:  Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares
Journal:  Intensive Care Med       Date:  2017-07-19       Impact factor: 17.440

6.  Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit.

Authors:  Stephen M Pastores; Debra A Goldman; David J Shaz; Natalie Kostelecky; Ryan J Daley; Tim J Peterson; Kay See Tan; Neil A Halpern
Journal:  Cancer       Date:  2018-05-04       Impact factor: 6.860

Review 7.  [Extracorporeal membrane oxygenation : System selection, (contra)indications, and management].

Authors:  T Staudinger
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05       Impact factor: 0.840

8.  Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.

Authors:  Elie Azoulay; Virginie Lemiale; Djamel Mokart; Saad Nseir; Laurent Argaud; Frédéric Pène; Loay Kontar; Fabrice Bruneel; Kada Klouche; François Barbier; Jean Reignier; Lilia Berrahil-Meksen; Guillaume Louis; Jean-Michel Constantin; Julien Mayaux; Florent Wallet; Achille Kouatchet; Vincent Peigne; Igor Théodose; Pierre Perez; Christophe Girault; Samir Jaber; Johanna Oziel; Martine Nyunga; Nicolas Terzi; Lila Bouadma; Christine Lebert; Alexandre Lautrette; Naike Bigé; Jean-Herlé Raphalen; Laurent Papazian; Michael Darmon; Sylvie Chevret; Alexandre Demoule
Journal:  JAMA       Date:  2018-11-27       Impact factor: 56.272

9.  Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients.

Authors:  Catherina Lueck; Michael Stadler; Christian Koenecke; Marius M Hoeper; Elke Dammann; Andrea Schneider; Jan T Kielstein; Arnold Ganser; Matthias Eder; Gernot Beutel
Journal:  Intensive Care Med       Date:  2018-08-23       Impact factor: 17.440

10.  Management of Acute Respiratory Failure in Patients With Hematological Malignancy.

Authors:  Rakesh Vadde; Stephen M Pastores
Journal:  J Intensive Care Med       Date:  2016-07-07       Impact factor: 3.510

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.